Stay updated on Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Addition of Revision v3.5.0 and deletion of Revision v3.4.3 in the record history.
    Difference
    0.1%
    Check dated 2026-03-21T08:37:40.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the record history and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-06T19:05:49.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added and the previous revision (v3.4.1) was deleted in the record history, indicating a minor metadata update to the study record history. No substantive changes to core study data or page content were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:42:19.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The record history shows a new revision entry (v3.4.1) added and a previous one (v3.4.0) removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T19:01:27.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The record history shows a new revision entry (v3.3.4) and removal of the previous revision (v3.3.3), indicating a backend update rather than changes to trial information.
    Difference
    0.1%
    Check dated 2026-01-15T03:18:16.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Revision: v3.3.3 has been added to the page history, and the 'HHS Vulnerability Disclosure' item along with the 'Revision: v3.3.2' entry were removed.
    Difference
    0.2%
    Check dated 2025-12-24T14:07:11.000Z thumbnail image

Stay in the know with updates to Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.